Improved health-related quality of life (QoL) of haemophilia B patients treated with a weekly 40 IU kg(-1) dose of a new long-acting recombinant factor IX (FIX) product, nonacog beta pegol
JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要